Matt Latham's practice focuses on mergers and acquisitions and private equity transactions. He has represented Australian and offshore acquirers and targets in a number of acquisitions, divestitures, take-private transactions, buyouts, and joint ventures. He also advises clients on various corporate-related matters, including directors' duties, corporate governance, and disclosure.
Matt has recently advised Australian Health Management in its A$367 million demutualisation and sale to Medibank Private; a consortium consisting of HarbourVest Partners, Paul Capital Partners, Pantheon Ventures, and Partners Group in its A$837 million take-private of Macquarie Capital Group Alliance; and Bear Stearns Private Equity in its A$115 take-private of Macquarie Private Capital Group.
Matt has published a number of articles and is a frequent speaker on mergers and acquisitions, private equity, and directors' duties.
"Absolute Liability" for a Failure to Prevent Foreign Bribery: Significant Change Ahead in Australia?
Frustrating Action and Asset Lock-Ups in Australia in Challenging Economic Conditions: The Takeover Panel's Perilya Decision
International Mergers & Acquisitions: Creating Value in an Increasingly Complex Corporate Environment, Financier Worldwide
The Use of Deal Protection Devices in Australia: Recent Trends and a Comparative Analysis With the US and UK
- February 23, 2010
2010 Speaker Series: Asia-Pacific, the Middle East, and Europe
- University of New South Wales (LL.B. 1992; B.A. 1992)
- New South Wales and Western Australia